Found: 26
Select item for more details and to access through your institution.
Emerging Pharmacological Treatments for Migraine in the Pediatric Population.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 4, p. N.PAG, doi. 10.3390/life12040536
- By:
- Publication type:
- Article
Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4665, doi. 10.3390/cancers13184665
- By:
- Publication type:
- Article
Patterns of anti‐CGRP mAbs use and variation of triptan consumption following treatment initiation: A descriptive drug utilization study in the Tuscany region, Italy.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1391, doi. 10.1111/head.14639
- By:
- Publication type:
- Article
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 2, p. 222, doi. 10.1111/head.14463
- By:
- Publication type:
- Article
Corrigendum: Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The TRPA1 Channel Amplifies the Oxidative Stress Signal in Melanoma.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 3131, doi. 10.3390/cells10113131
- By:
- Publication type:
- Article
Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine.
- Published in:
- CNS Drugs, 2023, v. 37, n. 2, p. 189, doi. 10.1007/s40263-022-00983-5
- By:
- Publication type:
- Article
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score.
- Published in:
- CNS Drugs, 2022, v. 36, n. 2, p. 191, doi. 10.1007/s40263-021-00893-y
- By:
- Publication type:
- Article
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. 1, doi. 10.3389/fneur.2021.673135
- By:
- Publication type:
- Article
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 415, doi. 10.1007/s40120-024-00582-0
- By:
- Publication type:
- Article
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system.
- Published in:
- PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0249681
- By:
- Publication type:
- Article
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. N.PAG, doi. 10.1371/journal.pone.0241575
- By:
- Publication type:
- Article
Clinically relevant drug interactions between statins and antidepressants.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 2, p. 227, doi. 10.1111/jcpt.13058
- By:
- Publication type:
- Article
Predictors of sustained response and effects of the discontinuation of anti‐calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 5, p. 1505, doi. 10.1111/ene.15260
- By:
- Publication type:
- Article
Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 1870, doi. 10.3390/jcm13071870
- By:
- Publication type:
- Article
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ).
- Published in:
- Neurological Sciences, 2023, v. 44, n. 8, p. 2845, doi. 10.1007/s10072-023-06758-0
- By:
- Publication type:
- Article
Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 1, p. 697, doi. 10.1007/s10072-021-05624-1
- By:
- Publication type:
- Article
The microbiota‐gut‐brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models.
- Published in:
- Bioengineering & Translational Medicine, 2022, v. 7, n. 2, p. 1, doi. 10.1002/btm2.10296
- By:
- Publication type:
- Article
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat.
- Published in:
- Epilepsia (Series 4), 2021, v. 62, n. 2, p. 529, doi. 10.1111/epi.16813
- By:
- Publication type:
- Article
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 11, p. 5436, doi. 10.1007/s00415-023-11872-2
- By:
- Publication type:
- Article
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 765, doi. 10.1007/s10120-021-01182-9
- By:
- Publication type:
- Article
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 4, p. 1, doi. 10.1177/03331024231160519
- By:
- Publication type:
- Article
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine.
- Published in:
- Cephalalgia, 2022, v. 42, n. 13, p. 1323, doi. 10.1177/03331024221111526
- By:
- Publication type:
- Article
Migraine Treatment: Towards New Pharmacological Targets.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12268, doi. 10.3390/ijms241512268
- By:
- Publication type:
- Article